Ph.D., VP, Translational Science, Celmatix Inc.
Biography
Dr. Cohn leads translational research initiatives at Celmatix, a precision health company advancing the fields of reproductive medicine and fertility at the intersection of big data and genomics. Her work is focused on using Reproductive Atlas, a multi-omic initiative that integrates diverse data sets that have been evaluated and curated by reproductive experts, for real-world evidence and therapeutic discovery in reproductive health. She holds dual B.S. degrees in Chemical Engineering and Biology from MIT and a Ph.D. in Cancer Biology from the Gerstner Sloan-Kettering Graduate School of Biomedical Science.
Clinical Dx Showcase:
Celmatix Inc.
Celmatix uses big data analytics and genomics to improve fertility treatments and pave the way for proactive fertility management.
Session Abstract – PMWC 2020 Silicon Valley
Track 6 - January 22 2.30 P.M.-3.45 P.M.,Track 7 - January 23 1.15 P.M.-1.30 P.M.,Track 6 - January 24 9.00 A.M.-1.15 P.M.
The PMWC 2020 Data Applications in Clinical Diagnostics Showcase will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
